Ligand validation:4AL9

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4AL9_EDO_A_1124	51%	73%	0.163	0.919	0.6	0.44	-	-	1	0	100%	1
4AL9_EDO_F_1126	43%	52%	0.156	0.88	0.84	1.02	-	-	0	0	100%	1
4AL9_EDO_D_1124	37%	79%	0.15	0.848	0.35	0.51	-	-	1	0	100%	1
4AL9_EDO_H_1122	31%	99%	0.202	0.869	0.1	0.14	-	-	1	0	100%	1
4AL9_EDO_F_1122	27%	62%	0.213	0.86	0.65	0.8	-	-	1	0	100%	1
7FIO_EDO_A_203	67%	71%	0.093	0.899	0.52	0.59	-	-	0	0	100%	1
6YO3_EDO_D_403	63%	94%	0.114	0.909	0.24	0.21	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
3G7R_EDO_B_961	100%	85%	0.035	0.988	0.45	0.3	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.